Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease – a prospective multicenter cohort study

Existing findings on outcomes of anti-tumor-necrosis-factor (TNF) therapy in patients with inflammatory bowel diseases (IBD) are largely based on retrospective studies. We aimed to investigate real-world outcomes of anti-TNF therapy and predictors thereof in a prospective IBD cohort.